Home › Bayer spending $100 million on Berkeley hemophilia drug facility
 

Keywords :   


Bayer spending $100 million on Berkeley hemophilia drug facility

2015-04-30 00:03:51| Chemicals - Topix.net

Bayer HealthCare is spending $100 million over the next two years building a product testing facility here for a new hemophilia drug, a project that will create 325,000 hours of construction work, officials said during a news conference Wednesday. Bayer's Berkeley campus, which spans three city blocks on 7th Street between Dwight Way and Grayson Street, manufactures a drug for people with hemophilia A called Kogenate.

Tags: million drug facility spending

Category:Chemicals

Latest from this category

All news
08.11Axalta Celebrates the Opening of its Global Headquarters in the Philadelphia Navy Yard
08.11Sheboygan Paint Company Names New Regional Sales Managers
08.11Polyurea-Based Lining is Key to GRE Pipeline Rehab Project in UAE
07.11The Lehigh Short Course Website is Now Open
07.11Carbon Trust Verifies Four BASF Intermediates
07.11Graco Completes Previously-Announced Acquisition of Corob
07.11PPG MOONWALK Paint Mixing System Now Has Customers in All 50 U.S. States
07.11 Arxada to Exhibit New Technology & Capabilities at Paints & Coatings Barcelona 2024
Chemicals »
08.11Bolt drivers win right to holiday and minimum wage
08.11INX details acquisition, SpectraGraphics grows and more
08.11Axalta Celebrates the Opening of its Global Headquarters in the Philadelphia Navy Yard
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 21
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11BW Converting assists SunDance with flexible packaging pivot
08.11Sheboygan Paint Company Names New Regional Sales Managers
More »